PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14895283-2	1951	Behavior of the insulin acidogram following tetraethylammonium administration].	Tetraethylammonium	44-62	insulin	Homo sapiens	16-23	
10715809-7	2000	However, the vascular relaxation caused by insulin and IGF-I was completely abolished by KCI, and was attenuated by the nonspecific potassium-channel blocker tetraethylammonium (for IMA rings, to 77 +/- 8 and 66 +/- 4% with insulin and IGF-I, respectively; for saphenous vein rings, 73 +/- 2 and 77 +/- 1% for insulin and IGF-I, respectively, P < 0.001).	Tetraethylammonium	158-176	insulin	Homo sapiens	43-50	
27920724-10	2016	In vessels pre-incubated with insulin, the constriction evoked by H2O2 and U46619 was attenuated and the effect on H2O2-induced constriction was blocked with tetraethylammonium and iberiotoxin, but not with genistein, or wortmannin.	Tetraethylammonium	158-176	insulin	Homo sapiens	30-37	
15800056-2	2005	Here we report that suppression of a voltage-gated K(+) channel with 4-aminopyridine (4-AP), barium, and tetraethylammonium inhibited both EGF- and insulin-stimulated myeloblastic leukemia ML-1 cell proliferation in a concentration-dependent manner.	Tetraethylammonium	105-123	insulin	Homo sapiens	148-155	
28116849-8	2017	Insulin secretion was also increased by inhibiting K channels other than KATP channels: Kv or BK channels (tetraethylammonium), TASK-1 channels (ML-365) and SK4 channels (TRAM-34).	Tetraethylammonium	107-125	insulin	Homo sapiens	0-7	
10715809-7	2000	However, the vascular relaxation caused by insulin and IGF-I was completely abolished by KCI, and was attenuated by the nonspecific potassium-channel blocker tetraethylammonium (for IMA rings, to 77 +/- 8 and 66 +/- 4% with insulin and IGF-I, respectively; for saphenous vein rings, 73 +/- 2 and 77 +/- 1% for insulin and IGF-I, respectively, P < 0.001).	Tetraethylammonium	158-176	insulin	Homo sapiens	224-231	
10715809-7	2000	However, the vascular relaxation caused by insulin and IGF-I was completely abolished by KCI, and was attenuated by the nonspecific potassium-channel blocker tetraethylammonium (for IMA rings, to 77 +/- 8 and 66 +/- 4% with insulin and IGF-I, respectively; for saphenous vein rings, 73 +/- 2 and 77 +/- 1% for insulin and IGF-I, respectively, P < 0.001).	Tetraethylammonium	158-176	insulin	Homo sapiens	224-231	
9719047-11	1998	KCl and TEA attenuated the vasorelaxation effect of both insulin and IGF-I.	Tetraethylammonium	8-11	insulin	Homo sapiens	57-64